Tuesday, December 2, 2008 - 11:07PM EST

Review Articles

21. Early detection and curative treatment of early-stage hepatocellular carcinoma.

Author
Kudo M;
Institution
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan. m-kudo@med.kindai.ac.jp
Journal
Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S144-8.
Abstract URL
Click here to view abstract

22. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

Author
Schwartz M; Roayaie S; Llovet J;
Institution
Recanati-Miller Transplantation Institute, Mount Sinai School of Medicine, New York, USA. myron.schwartz@mssm.edu
Journal
J Hepatol. 2005 Oct;43(4):584-9.

23. Emerging drugs for hepatocellular carcinoma.

Author
Roberts LR; Gores GJ;
Institution
Mayo Clinic College of Medicine, Miles and Shirley Fiterman Center for Digestive Diseases, 200 First Street SW, Rochester, MN 55905, USA. Roberts.Lewis@mayo.edu
Journal
Expert Opin Emerg Drugs. 2006 Sep;11(3):469-87.
Abstract URL
Click here to view abstract

24. Liver transplantation for hepatocellular carcinoma: an update.

Author
Botha JF; Langnas AN;
Institution
Department of Surgery, Section of Transplantation, UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE 68198-3285. jbotha@unmc.edu
Journal
J Natl Compr Canc Netw. 2006 Sep;4(8):762-7.
Abstract URL
Click here to view abstract

25. Liver-directed therapies for hepatocellular carcinoma.

Author
Arciero CA; Sigurdson ER;
Institution
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Journal
J Natl Compr Canc Netw. 2006 Sep;4(8):768-74.
Abstract URL
Click here to view abstract

26. Liver-directed therapies for patients with primary liver cancer and hepatic metastases.

Author
Arciero CA; Sigurdson ER;
Institution
Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Journal
Curr Treat Options Oncol. 2006 Sep;7(5):399-409.
Abstract URL
Click here to view abstract

27. Opportunities for targeted therapies in hepatocellular carcinoma.

Author
Thomas MB; Abbruzzese JL;
Institution
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. methomas@mdanderson.org
Journal
J Clin Oncol. 2005 Nov 1;23(31):8093-108.
Abstract URL
Click here to view abstract

28. Transarterial chemoembolization in a patient with recurrent hepatocellular carcinoma and portal vein thrombosis: a case report and review of the literature.

Author
Sikander A; Sadashiv S; Ronald S; Milind J;
Institution
Department of Medicine, Roswell Park Cancer Institute and State University of New York at Buffalo, NY 14263, USA. ailawadhi77@yahoo.com
Journal
Am J Clin Oncol. 2005 Dec;28(6):638-9.
Abstract URL
Click here to view abstract

29. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.

Author
Pang R; Poon RT;
Institution
Department of Medicine, Centre for Cancer Research, The University of Hong Kong, Pokfulam, Hong Kong, China.
Journal
Cancer Lett. 2006 Oct 28;242(2):151-67. Epub 2006 Mar 27.
Abstract URL
Click here to view abstract

30. Radiofrequency ablation for malignant liver tumor.

Author
Ng, Kelvin K; Poon, Ronnie T;
Institution
Department of Surgery, Centre for the Study of Liver Disease, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.
Journal
Surg Oncol 2005 Jul;14(1):41-52.
Abstract URL
Click here to view abstract
Pages: 1 2 3